State legislative sessions are typically a flurry of health policy activity. In recent years, state lawmakers have taken action to stabilize their insurance markets and increase access to coverage. But like so many other constants we have come to rely on, state legislative sessions took a hit this year from the novel coronavirus pandemic, putting current and future state policy initiatives in jeopardy.
In December, President Trump signed the Republican tax reform bill into law, which among other things, eliminates the health insurance mandate penalty and reduces the corporate tax rate from 35 to 21 percent. The bill provides for $1.5 trillion in tax cuts over the next decade, mostly benefiting high-income earners and corporations, which Republicans hope will stimulate economic growth. Now, a few months into effect health care companies are taking stock of how the tax law benefits their bottom line and how to best invest the savings for future success. CHIR’s Emily Curran looks into how some state regulators are reacting.
The opinions expressed here are solely those of the individual blog post authors and do not represent the views of Georgetown University, the Center on Health Insurance Reforms, any organization that the author is affiliated with, or the opinions of any other author who publishes on this blog.
